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Abstract
Background: Untimely diagnosis of intracranial hypertension may lead to delays in therapy and worsening of
outcome. Transcranial Doppler (TCD) detects variations in cerebral blood flow velocity which may correlate with
intracranial pressure (ICP). We investigated if intracranial hypertension can be accurately excluded through use of
TCD.
Method: This was a multicenter prospective pilot study in patients with acute brain injury requiring invasive
ICP (ICPi) monitoring. ICP estimated with TCD (ICPtcd) was compared with ICPi in three separate time frames:
immediately before ICPi placement, immediately after ICPi placement, and 3 hours following ICPi positioning.
Sensitivity and specificity, and concordance correlation coefficient between ICPi and ICPtcd were calculated.
Receiver operating curve (ROC) and the area under the curve (AUC) analyses were estimated after measurement
averaging over time.
Results: A total of 38 patients were enrolled, and of these 12 (31.6%) had at least one episode of intracranial
hypertension. One hundred fourteen paired measurements of ICPi and ICPtcd were gathered for analysis. With
dichotomized ICPi (≤20 mmHg vs >20 mmHg), the sensitivity of ICPtcd was 100%; all measurements with high
ICPi (>20 mmHg) also had a high ICPtcd values.
Bland-Altman plot showed an overestimation of 6.2 mmHg (95% CI 5.08–7.30 mmHg) for ICPtcd compared to ICPi.
AUC was 96.0% (95% CI 89.8–100%) and the estimated best threshold was at ICPi of 24.8 mmHg corresponding to
a sensitivity 100% and a specificity of 91.2%.
Conclusions: This study provides preliminary evidence that ICPtcd may accurately exclude intracranial hypertension
in patients with acute brain injury. Future studies with adequate power are needed to confirm this result.
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Background
Brain injury is frequently accompanied by episodes of
intracranial hypertension, which is a potentially fatal
condition [1–3]. Timely diagnosis through intracranial
pressure (ICP) monitoring becomes fundamental in
order to guarantee prompt diagnosis and appropriate
therapeutic decision-making. Presently, the gold stand-
ard for continuous ICP monitoring is invasive measure-
ment through insertion of a catheter within the brain
ventricles (EVD) connected to an external pressure
transducer [4, 5]. However, this method may be cumber-
some, not always available, and accompanied by an elevated
complication rate due mostly to infection, hemorrhage,
and catheter obstruction [6–9]. Brain intraparenchimal
catheters, despite being safer, still require an invasive
procedure and cannot be recalibrated once inserted,
rendering the measurements prone to imprecision due
to zero drift [10–12].
Numerous alternatives to invasive ICP measure-
ment have been proposed in the literature. Although
some techniques have potential as screening methods
for intracranial hypertension, none have found a valid
place within daily clinical practice [13–16]. Among
these, methods which use transcranial Doppler
(TCD) provide valuable information, as cerebral
blood flow velocity has been shown to correlate with
ICP [17–22]. In this study, we investigated if ICP es-
timated by means of TCD (ICPtcd) accurately identi-
fies intracranial hypertension in patients with acute
severe brain injury.
Methods
Project setting and design
This was a prospective multicenter pilot study and
took place between November 2013 and August 2014
in six neurocritical care units (Brescia Spedali Civili
University Hospital; Brescia Fondazione Poliambulanza;
Pisa Azienda Ospedaliera Cisanello; Lecco Azienda
Ospedaliera A. Manzoni; Varese Ospedale di Circolo
Fondazione Macchi; Genova Ospedale Galliera). The
Brescia University Hospital served as the coordinating
center for the study. Ethics approval for all participat-
ing sites was obtained from the appropriate regulatory
committees. Detailed written information was provided
to the family members regarding the study protocol,
the scope of research, and the safety of TCD examin-
ation. Since all patients had altered consciousness, the
ethics committees waived the requirement for consent,
as in Italy relatives are not regarded as legal representa-
tives of the patient in the absence of a formal designa-
tion [23]. Written informed consent was requested
from all surviving patients as soon as they regained
their mental competency (NP 1892 – EudraCT: 2014-
005482-71).
Patients were included if they were 18 years or older,
had sustained acute brain injury and required invasive
ICP monitoring within the first 24 hours of ICU admis-
sion. They were excluded if they had any one of the
following: inaccessible or poor acoustic ultrasound win-
dow, a cardiovascular disease causing hemodynamic var-
iations affecting the TCD reading (severe arrhythmia,
cardiac valvular stenosis, severe vascular sclerosis), de-
compressive craniectomy, or any treatment for intracra-
nial hypertension intervening between the invasive ICP
(ICPi) and ICPtcd measurements. Patient sedation for
ICP bolt placement consisted of bolus followed by con-
tinuous infusion of propofol or midazolam, fentanyl, and
when necessary, neuromuscular blockade through bolus
infusions of atracurium besylate. Mechanical ventilation
was targeted to maintain adequate oxygenation (SaO2 >
90%) and normocapnia (PaCO2 36–40 mmHg). Intra-
venous fluids and inotropic support (norepinephrine
and/or epinephrine) were provided as appropriate in
order to achieve and maintain a sufficient cerebral perfu-
sion pressure (CPP >60 mmHg). General management of
the various types of brain injury (traumatic, hemorrhagic,
or ischemic), as well as the definition of intracranial
hypertension, were in accordance to international guide-
lines [24–29]. Treatment of intracranial hypertension was
based on a protocol-driven strategy which included
optimization of arterial blood pressure and volemia, sed-
ation, mild hyperventilation, and infusion of hyperosmolar
fluids [30].
Patient monitoring
Systemic hemodynamic monitoring consisted of invasive
arterial blood pressure (ABP) from the radial artery, con-
tinuous electrocardiography and pulse oximetry. ICPi was
performed either by means of an intraparenchymal fiber-
optic transducer (Camino Laboratories, Integra NeuroSci-
ences, San Diego, CA, USA), or a catheter inserted into
the brain ventricles and connected to an external pressure
transducer and drainage system (Codman, Johnson &
Johnson Medical Ltd., Raynham, MA, USA). Cerebral
blood flow velocity was assessed using TCD sonography
(DWL 2000 Multidop X2, Compumedics DWL, Singen,
Germany), and was performed by a selected group of
experienced operators in order to reduce inter-operator
variability. The insonation technique was standard: a low-
frequency pulsed 2 MHz ultrasound probe was placed
over the acoustic temporal window for insonation of the
M1/M2 section of the middle cerebral artery (MCA) at a
depth ranging from 45 to 55 mm [31–33]. The MCAs
were insonated bilaterally; however, for ICPtcd measure-
ment the acoustic window ipsilateral to the side of ICP
bolt placement was used.
ICPtcd was calculated using the following equations
(1 and 2) [21, 22]:
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ICPtcd ¼MAP – CPPe ð1Þ
CPPe ¼MAP FVdia =FVm‐1 þ 14 ð2Þ
where MAP represented the mean arterial pressure,
CPPe the estimated CPP, FVdia and FVm were, respect-
ively, the diastolic and mean flow velocities, as measured
by TCD. The ICPi and MAP readings used for calculations
were recorded simultaneously in order to standardize
measurements.
Study design
For each patient enrolled into the study, a total of three
ICPtcd measurements were performed, each of which
was compared to the corresponding ICPi for concord-
ance. The first ICPtcd measurement (TIME 1) was per-
formed immediately before ICPi placement and was
compared with the first ICPi reading once the probe was
positioned. The need to reduce the time gap as much as
possible between the two readings was motivated by the
fact that ICP may be subjected to variations caused by
ABP manipulation, cerebrospinal fluid (CSF) leakage
during catheter placement and pharmacological treat-
ment or fluctuations due to the evolving underlying
brain injury. The second ICPtcd measurement (TIME 2)
was performed immediately after insertion of the ICPi
probe and compared with the post-insertion ICPi read-
ing. The third ICPtcd measurement (TIME 3) was per-
formed between 2 and 3 hours following the second
reading. The reason for this was to avoid any possible
variations in systemic and cerebral hemodynamics
caused by the ICPi device insertion itself, despite sed-
ation. Therefore, performing the examination more than
2 hours post insertion should reduce the influence of the
positioning maneuver on the readings. In accordance
with the guidelines present during the study period,
intracranial hypertension was defined as an ICP above
20 mmHg, which remained so for at least 10 minutes
and was not related to procedural pain [12].
Statistical analysis
Continuous variables were expressed as means standard
deviation (SD) or as medians (interquartile range, IQR) as
appropriate, and discrete variables as counts (percentage).
Concordance correlation coefficients were calculated
for ICPi and ICPtcd both in patients receiving EVD and
intraparenchimal ICP monitoring. These two correlation
coefficients were compared by mean of Fisher trans-
formation test, for TIME 1, in order to account for
differences due to the possibility of CSF leakage dur-
ing EVD placement.
Agreement between ICPtcd and ICPi measurements
was evaluated both on the continuous raw scale and
after categorization based on common usage threshold
for ICP (20 mmHg) [34, 35]. Concordance correlation
coefficient between ICPi and ICPtcd for repeated mea-
surements was calculated using variance components es-
timated through linear mixed model, adjusting for ICPi
in the three separate time frames described above [36].
A Bland-Altman plot was computed for agreement, as-
suming constant bias and accounting for linked repeated
measures. Linked repeated measures (TIME) were also
accounted for variance components and were estimated
using Markov chain Monte Carlo [37].
Receiver operating curve (ROC) and the area under
the curve (AUC) were estimated after measurement
averaging over time. Values of ICPi were dichotomized
using a standard reference value of 20 mmHg [34, 35].
Confidence interval for AUC, sensitivity and specificity
were computed using bootstrapping (B = 10000) [37].
Youden statistics criterion was used to evaluate the per-
formance of ICPtcd (best combination of sensitivity and
specificity) [38]. The sensitivity was expressed as the
probability that a patient with high ICPi (>20 mmHg)
would also have a high ICPtcd value, and the specificity
as the probability that a patient with normal ICPi
(≤20 mmHg) would also have a normal ICPtcd value.
Best threshold for marker was computed using Youden
criterion [38–40].
Sample size for a future study was estimated using the
procedure proposed by Flahault et al. and Chu et al., as-
suming a sensitivity of the test (ICPtcd) of 90%, a preva-
lence of the disease (intracranial hypertension) equal to
30%, statistical power of 95% and a minimal acceptable
lower confidence limit of 10% [41, 42].
R software was used for statistical analysis (version 3.2.5,
Free Software Foundation, Inc., Boston, MA, USA).
Results
From November 2013 to August 2014, a total of 38
patients with acute brain injury were enrolled. Patient
demographics, causes of brain injury requiring ICPi
monitoring, and types of monitoring techniques are
described in Table 1.
ICP monitoring was initiated in all patients within
24 hours following acute brain injury. EVD was placed
Table 1 General characteristics and admission diagnoses










TBI 20 45.1 (12.8) 4/20 16/20 8/20
aSAH 11 61.4 (9) 6/11 5/11 2/11
ICH 7 72.6 (5.7) 0/7 7/7 2/7
TOT cohort 38 57.8 (15.7) 10/38 28/38 12/38
aSAH aneurysmal subarachnoid hemorrhage, EVD external ventricular drain,
ICH intracerebral hemorrhage, ICHT intracranial hypertension, TBI traumatic
brain injury
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in 10 patients, the other 28 received intraparenchimal
catheter monitoring. The Fisher transformation analysis of
the correlation coefficient for TIME 1 between ICPtcd-IP
and ICPtcd-EVD showed no differences (p = 0.35), there-
fore the subsequent analyses were performed without
dividing the invasive measurements from IP or EVD.
A total of 114 ICPtcd examinations in three separate
time frames were performed in 38 patients, 105 ipsilat-
eral to the ICPi placement and 9 contralateral. The most
common reasons for not being able to access the ipsilat-
eral sides were due to an inaccessible acoustic window
(60%) and a poor signal (40%). Due to a temporary
unavailability of the TCD machine, a transcranial color-
coded duplex Doppler was used for ICPtcd measurements
in one patient. However, we did not exclude this patient
since both ICPi and ICPtcd readings corresponded to
values <20 mmHg, and therefore their exclusion would
not have modified the results.
As for protocol, during the measurements the PaCO2
in all patients remained within the 36–40 mmHg target
range.
In the 38 patients enrolled, 12 (31.6%) had at least one
episode of intracranial hypertension. Of the 114 ICPtcd/
ICPi paired readings, elevated ICP was present in 20/114
measurements (17.5%) according to ICPi, and in 41
(35.6%) according to ICPtcd (Table 2). In 6/114 (5%)
measurements, the ICPtcd was lower than the corre-
sponding ICPi reading, while in 108/114 (95%) measure-
ments the ICPtcd was higher (Fig. 1). With dichotomized
ICPi (≤20 mmHg vs >20 mmHg), the sensitivity of ICPtcd
was 100%, all patients with ICPi >20 mmHg also had
ICPtcd >20, no false negatives.
Figure 2 shows the estimated conversion between
ICPtcd and ICPi; the slope value was 1.02 (95% CI 0.85–
1.36), which accounts for a 2% increase in bias for unit of
ICP (p = 0.59), meaning a significant correlation between
the measurements provided by the two techniques.
The Bland-Altman plot shows an overestimation of
6.2 mmHg (95% CI 5.08–7.30 mmHg) for ICPtcd com-
pared to ICPi, with an agreement range from -5.6 to
18 mmHg (Fig. 3).
With a ROC curve analysis for ICPtcd averaged over
times (TIME 1, TIME 2, and TIME 3), the AUC was
96.0% (95% CI 89.8–100%) and the estimated best
threshold was at ICPi of 24.8 mmHg corresponding to a
sensitivity 100% and a specificity of 91.2% (Fig. 4).
The estimated AUC and bootstrapped 95% CI for ROC
were estimated at three separate time points (TIME 1,
TIME 2, and TIME 3) and the AUC averaged over time.
Pairwise comparisons between different AUC did not
show any statistically significant difference (1 vs 2, p =
0.80; 1 vs 3, p = 0.99, 2 vs 3, p = 0.78), indicating that
ICPtcd estimation of ICPi was time independent.
Discussion
This is the first prospective multicenter pilot study per-
formed in a cohort of brain-injured patients which
showed that ICPtcd had a 100% sensitivity in excluding
intracranial hypertension when compared to ICPi. Al-
though the patients were exposed to few episodes of
high ICP, this result held true for all values of ICPi above
20 mmHg. The best threshold was at ICPi of 24.8 mmHg
corresponding to an ICPtcd sensitivity of 100% and a
specificity of 91.2%. ICPtcd was higher than ICPi in the
large majority of measurements, which was reflected in
the Bland-Altman analysis yielding a mean bias of +
6.2 mmHg. This emphasizes the finding that in patients
with acute brain injury recruited in our study, if the
ICPtcd was normal, ICPi was certainly normal.
The main goal of our study was to evaluate if ICPtcd
could represent a noninvasive screening method to ex-
clude patients without intracranial hypertension and
therefore not requiring invasive measurement. There is
extensive literature proposing TCD as a tool for nonin-
vasive assessment of ICP [15–22]. In fact, published
studies have shown a good concordance between overall
ICPi and ICPtcd values. Yet none of these studies have
specifically sought to demonstrate that normal ICPtcd
can accurately exclude intracranial hypertension. Our re-
sults are consistent with a recent multicenter study in
356 traumatic brain injury patients which showed that
TCD had a negative predictive value of 98% in excluding
neurologic worsening. However, comparison with ICPi
was not possible due to the fact that the study enrolled
patients with mild to moderate traumatic brain injury.
Moreover, the study used the pulsatility index (PI) and
Table 2 Invasive (ICPi) and transcranial Doppler (ICPtcd) intracranial pressure (ICP) measurements at study times









TIME 1 20.5 (9.1) 13.5 (8.0) 18 (47.3%) 10 (26.3%)
TIME 2 16.7 (7.7) 11.1 (7.8) 10 (26.3%) 4 (10.5%)
TIME 3 17.5 (8.7) 11.5 (8.0) 13 (34.2%) 6 (15.8%)
Overall 18.2 (8.6) 12.0 (7.9) 21 (55.3%) 12 (31.6%)
TIME1 ICPtcd immediately before ICPi insertion, TIME 2 ICPtcd immediately after ICPi insertion, TIME 3 from 2 to 3 h following ICPi insertion
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diastolic blood flow velocity as TCD parameters to pre-
dict neurologic worsening [43]. TCD-derived PI methods
are based on observation that ICP and PI are positively
correlated during increases of ICP. However, increase in
PI is not specific for increase in ICP. In certain situa-
tions, such as a drop in CPP, PI presents an increasing
trend, which can be related to either increases in ICP or
decreases in arterial blood pressure. The same behavior
occurs during decrease in PaCO2 or increase in pulsati-
lity of arterial blood pressure waveform. We used the
equation for noninvasive measurement of CPP (CPPe =
MAP · FVdia/FVm-1 + 14) proposed by Czosnyka and
colleagues based on the fact that specific patterns of
TCD waveform, such as a decrease in diastolic flow
velocity, reflect impaired cerebral perfusion caused by
a decrease in CPP. This formula provides a quantita-
tive assessment of CPP from which ICP can be de-
rived [19–22, 44].
In a recent study, Cardim and colleagues evaluated
four methods for noninvasive measurement of ICP; a
“black-box” model based on interaction between TCD
and arterial blood pressure (nICP_BB); a model based
on diastolic flow velocity (nICP_FVd); one based on crit-
ical closing pressure (nICP_CrCP); and one on TCD-
derived pulsatility index (nICP_PI). The first three
methods proved to be the best estimators of measured
ICP. We believe these findings strengthen our results,
since the method we used was indeed the FVd model.
Despite that nICP_FVd had a greater 95% CI for predic-
tion of ICP compared to the other two estimators, it was
associated with only a marginally better AUC [45].
Although at present ICPtcd cannot replace ICPi as the
gold standard for ICP measurement, this simple and
cost-effective method incurs no harm to the patient and
provides a method of quickly excluding intracranial
hypertension in brain-injured patients in the early phase
of hospital admission, when other means are unavailable
or contraindicated and when saving time is of para-
mount importance. In fact, following acute brain injury
precious time is frequently lost before adequate cerebral
monitoring can be initiated. During triage of polytrauma
patients within the emergency department, ICPtcd may
be helpful in prioritizing treatment when extracerebral
Fig. 1 Dichotomized ICP readings, ≤20 mmHg vs >20 mmHg, ≤24.8 mmHg vs >24.8 mmHg. ICPi invasive intracranial pressure, ICPtcd transcranial
Doppler estimation of intracranial pressure
Fig. 2 Estimated conversion between ICPtcd and ICPi; slope value = 1.02
(95% CI 0.85–1.36). ICPi invasive intracranial pressure, ICPtcd transcranial
Doppler estimation of intracranial pressure
Fig. 3 Bland-Altman plot showing mean bias of + 6.2 mmHg for
ICPtcd compared to ICPi, with an agreement range from -5.6 to
18 mmHg. ICPi invasive intracranial pressure, ICPtcd transcranial
Doppler estimation of intracranial pressure
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lesions are also involved. Also, on admittance to the
emergency department, comatose patients can benefit
from early TCD evaluation, which provides valuable in-
formation regarding ICP and cerebral perfusion [43].
Admission diastolic flow velocity <25 cm/s and pulsati-
lity index >1.3 in adults and children with head injury
have been associated with a poor outcome [43–49]. In a
series of 28 severe traumatic brain injury (TBI) patients
the authors performed a TCD examination before ICPi
monitoring was initiated and identified cerebral hypo-
perfusion in 46% of patients, which prompted the clini-
cians to optimize CPP management [49]. Even in the
prehospital setting, TCD is feasible and can assist in
optimizing early goal-directed therapy [50]. The ICPtcd
measurements in our study were performed within
24 hours from brain injury and as soon as possible fol-
lowing ICU admission.
We used a cutoff value of 20 mmHg to define intra-
cranial hypertension, according to the recommendations
available at the time the study took place. Current guide-
lines of the Brain Trauma Foundation indicate that
higher ICP values (22 mmHg) should be considered as a
threshold [51–54]. We found that ICPtcd sensitivity
remained 100% also for all explored values of ICPi above
20 mmHg. Indeed, ROC analyses estimated the best cut-
off for sensitivity (100%) and specificity (91.2%) to be at
24.8 mmHg. However, this analysis was based on few
measurements of intracranial hypertension episodes, and
requires further investigation.
As a pilot study, we also aimed at calculating a sample
size for a future larger and more definite trial. In the lit-
erature, the prevalence of intracranial hypertension in
the categories of acute brain injury taken into consider-
ation in this study [TBI, subarachnoid hemorrhage
(SAH), and intracerebral hemorrhage (ICH)], ranged
from 36% to 77% [3, 55–57]. Using the calculation
method mentioned previously, we estimate a sample size
of 490 patients [41, 42].
Limitations
Some study limitations are worth considering. First, TCD
readings were intermittent and not continuous. However,
TCD is a noninvasive method which can be rapidly per-
formed and repeated as many times as needed. Second, we
enrolled patients with different types of brain injury, includ-
ing subarachnoid hemorrhage, intracerebral hemorrhage
and stroke, for whom ICP thresholds are not well defined.
Small sample size precluded us from comparing the diag-
nostic accuracy of TCD in different diagnostic categories.
Third, the study was unblinded; ICPi and MAP were re-
corded simultaneously in order to reduce the possibility of
value selection during the readings. Finally, most of the 114
measurements had ICP <20 mmHg (94/114), there-
fore the cohort of brain-injured patients was exposed
to few episodes of high ICP.
Conclusions
This prospective multicenter pilot study provides pre-
liminary evidence that ICP estimated with TCD was in
line with true ICP in excluding intracranial hypertension.
Since the brain-injured patients in our study were ex-
posed to few episodes of high ICP, a study including a
greater amount of brain-injured patients with high ICP
is warranted.
A large study aiming at enrolling 490 patients is under
way (https://www.clinicaltrials.gov - Invasive vs noninva-
sive Measurement of intracranial PRESSure in brain Injury
Trial [IMPRESSIT]).
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